http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_792ff3ea9a626704a311e3229470b972
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Prabhakar |
| name | Uma Prabhakar |
| given-name | Uma |
| organization-name | Department of Clinical Pharmacology, Centocor Inc., Malvern, PA, USA. Centocor Inc., Horsham, Pennsylvania. 6Clinical Pharmacology, and Authors' Affiliations: 1Alliance for Nanotechnology in Cancer, National Cancer Institute, Bethesda, Maryland; 2Institute for DDS Research, Sojo University, Kumamoto, Japan; 3Harvard Medical School and Massachusetts General Hospital; 4Harvard Medical School and Brigham and Womens Hospital, Boston, Massachusetts; 5Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, Texas; 6UNC Eshelman School of Pharmacy, UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; 7AstraZeneca, Alderley Park, Macclesfield, United Kingdom; and 8Shaare Zedek Medical Center and Hebrew University-School of Medicine, Jerusalem, Israel Consultant to the Office of Cancer Nanotechnology Research, Center for Strategic Scientific Initiatives, National Cancer Institute, NIH, Bethesda, MD 20892, USA Department of Clinical Pharmacology, Centocor Inc. Authors' Affiliations: 1Centocor, Research & Development, Inc., Malvern, Pennsylvania and 2Centocor, Research & Development, Inc., High Wycombe, United Kingdom |
Incoming Links
Total number of triples: 35.